Leukemia & Lymphoma Society: Translational Research Program (LOI)

Supports approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions. Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. The application should have a clear plan for the eventual clinical translation of the basic research findings and the results expected. Special point of interest in this RFP is Prevention of disease by detection and/or treatment of pre-blood cancerous states, smoldering low-grade disease, or relapse using state-of-the-art methodologies and new therapies.

LLS-Snowdome Foundation-Leukaemia Foundation cooperation is offering two additional grants where at least one PIs must be Australian.

Funding: Up to $650,000 for 3 years.

Overhead 11%. Nonprofit - Please contact Research Authority if planning to submit.

https://www.lls.org/research/translational-research-program